Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tandem Diabetes Care

21.48
+1.507.51%
Post-market: 21.00-0.4800-2.23%18:42 EDT
Volume:1.99M
Turnover:42.15M
Market Cap:1.43B
PE:-7.66
High:21.64
Open:20.25
Low:19.90
Close:19.98
Loading ...

Stock Track | Tandem Diabetes Care Stock Soars 5% on Strong Q1 Revenue Growth Despite Earnings Miss

Stock Track
·
Yesterday

Tandem Diabetes Care Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Yesterday

Stock Track | Tandem Diabetes Care Soars 14.54% on Strong Q1 Results and Robust Global Growth

Stock Track
·
01 May

Tandem Diabetes Care Is Maintained at Neutral by Baird

Dow Jones
·
01 May

Stock Track | Tandem Diabetes Care Soars 9.79% Pre-market on Stellar Q1 Results and Strong Growth Outlook

Stock Track
·
01 May

Stock Track | Tandem Diabetes Care Soars 9.79% Pre-market on Stellar Q1 Results and Strong Growth Outlook

Stock Track
·
01 May

Tandem Diabetes price target raised to $59 from $58 at Canaccord

TIPRANKS
·
01 May

Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com
·
01 May

Tandem Diabetes Care Surges on Strong Q1 Revenue Beat and Robust Growth

Stock Track
·
01 May

24H | Align, Tandem Diabetes Shares Soar 10% on Earnings Beat; Crypto Shares Rally With CleanSpark, Riot Platforms up 3%

Tiger Newspress
·
01 May

Stock Track | Tandem Diabetes Care Soars 10.21% on Strong Q1 Revenue Beat and Robust Growth Outlook

Stock Track
·
01 May

Tandem Diabetes Care’s Strong Q1 Performance and Growth Drive Buy Rating

TIPRANKS
·
01 May

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
01 May

Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

StockStory
·
01 May

Tandem Diabetes Care Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Stock Track | Tandem Diabetes Care Surges 5.34% After-Hours on Strong Q1 Sales Beat and Solid Guidance

Stock Track
·
01 May

Tandem Diabetes Care Q1 Adj. EPS $(0.67) Misses $(0.61) Estimate, Sales $234.42M Beat $220.20M Estimate

Benzinga
·
01 May

Tandem Diabetes Care Q1 GAAP EPS $(1.97), Sales $234.42M Beat $220.20M Estimate

Benzinga
·
01 May

Tandem Diabetes sees FY25 revenue $997M-$1.007B, consensus $999M

TIPRANKS
·
01 May

BRIEF-Tandem Diabetes Care Q1 Gross Margin 51%

Reuters
·
01 May